Safety and pharmacokinetics of BAY 1817080, a P2X3 receptor antagonist, in healthy subjects: Results from a double-blind, randomised study

Friedrich Christian; Francke Klaus; Gashaw Isabella; Scheerans Christian; Klein Stefan; Fels Lueder; Smith Jaclyn; Hummel Thomas; Morice Alyn

首页> 外文期刊>British Journal of Clinical Pharmacology >Safety and pharmacokinetics of BAY 1817080, a P2X3 receptor antagonist, in healthy subjects: Results from a double-blind, randomised study

【24h】

Safety and pharmacokinetics of BAY 1817080, a P2X3 receptor antagonist, in healthy subjects: Results from a double-blind, randomised study

机译：P2X3受体拮抗剂Bay 1817080的安全和药代动力学，在健康的主题中：双盲，随机研究结果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《British Journal of Clinical Pharmacology》 |2021年第3期|共3页
作者
Friedrich Christian; Francke Klaus; Gashaw Isabella; Scheerans Christian; Klein Stefan; Fels Lueder; Smith Jaclyn; Hummel Thomas; Morice Alyn;
展开▼
作者单位

Bayer AG Leverkusen Germany;

Bayer AG Leverkusen Germany;

Bayer AG Leverkusen Germany;

Bayer AG Leverkusen Germany;

Bayer AG Leverkusen Germany;

Bayer AG Leverkusen Germany;

Univ Manchester Immun &

Resp Med Manchester Lancs England;

Tech Univ Dresden Dept Otorhinolaryngol Smell &

Taste Clin Dresden Germany;

Univ Hull Resp Res Grp Hull York Med Sch Kingston Upon Hull N Humberside England;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词

相似文献

外文文献
中文文献
专利

1. Safety, pharmacokinetics, and biomarkers of F-652, a recombinant human interleukin-22 dimer, in healthy subjects [J] . Kai-Yang Tang, Jason Lickliter, Zhi-Hua Huang, 细胞与分子免疫学：英文版 . 2019,第005期
2. Optimization and validation of a fast RP-HPLC method for the determination of dobutamine in rat plasma:Pharmacokinetic studies in healthy rat subjects [J] . Ramesh Thippani, Nageswara Rao Pothuraju, Nageswara Rao Ramisetti, 药物分析学报（英文） . 2013,第006期
3. Safety and pharmacokinetic profile of ascending doses of AT-1015, a novel 5-HT_2A receptor antagonist, in combination with low-dose aspirin: two randomised, placebo-controlled, double-blind studies [J] . Kazuya Onomichi, Hirohisa Uchida, Sarah Shelley, Journal of drug assessment . 2003,第3期

机译：新型5-HT_2A受体拮抗剂AT-1015联合小剂量阿司匹林的递增剂量的安全性和药代动力学特征：两项随机，安慰剂对照，双盲研究
4. Safety and pharmacokinetic profile of ascending doses of AT-1015, a novel 5-HT_2A receptor antagonist, in combination with low-dose aspirin: two randomised, placebo-controlled, double-blind studies [J] . Kazuya Onomichi, Hirohisa Uchida, Sarah Shelley, Journal of drug assessment . 2003,第3期

机译：新型5-HT_2A受体拮抗剂AT-1015联合小剂量阿司匹林的递增剂量的安全性和药代动力学特征：两项随机，安慰剂对照，双盲研究
5. P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study [J] . Abdulqawi Rayid, Dockry Rachel, Holt Kimberley, The Lancet . 2015,第9974期

机译：难治性慢性咳嗽中的P2X3受体拮抗剂（AF-219）：一项随机，双盲，安慰剂对照的2期研究
6. Double-Blind Single-Session Neurofeedback Training in Upper-Alpha for Cognitive Enhancement of Healthy Subjects [C] . C. Escolano, B. Olivan, Y. Lopez-del-Hoyo, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2012

机译：用于高α的双盲单会话神经融合训练，用于健康受试者的认知增强
7. Pharmacokinetic Evaluation of a Novel Compound, SN79, a Putative Sigma-2 Receptor Antagonist, by Intravenous and Oral Administration in Rats. [D] . Vinnakota, Harsha. 2011

机译：通过大鼠静脉内和口服给药对新型化合物SN79（一种公认的Sigma-2受体拮抗剂）进行药代动力学评估。
8. Safety tolerability pharmacokinetics and pharmacodynamics of GSK2239633 a CC-chemokine receptor 4 antagonist in healthy male subjects: results from an open-label and from a randomised study [O] . Anthony Cahn, Simon Hodgson, Robert Wilson, 2013

机译：CC-趋化因子受体4拮抗剂GSK2239633在健康男性受试者中的安全性耐受性药代动力学和药效学：来自开放标签和随机研究的结果
9. Safety and Efficacy of BAY 1817080, a P2X3 Receptor Antagonist, in Patients with Refractory Chronic Cough (RCC) [O] . A.H. Morice, J. Smith, L. McGarvey, 2020

机译：Bay 1817080，P2X3受体拮抗剂，难治性慢性咳嗽患者（RCC）的安全性和有效性
10. Evaluation of In Vitro Cross-Reactivity to Avian H5N1 and Pandemic H1N1 2009 Influenza Following Prime Boost Regimens of Seasonal Influenza Vaccination in Healthy Human Subjects: A Randomised Trial. [R] . Bethell, D., Saunders, D., Jongkaewwattana, A., 2013

机译：在健康人类受试者中季节性流感疫苗接种的prime Boost方案后对禽流感H5N1和甲型H1N1流感的体外交叉反应性的评估：随机试验。

Safety and pharmacokinetics of BAY 1817080, a P2X3 receptor antagonist, in healthy subjects: Results from a double-blind, randomised study

著录项

相似文献

相关主题

期刊订阅